Company Description

Immunovive's mission is to accelerate life science research and biologics discovery by providing a high-quality antibody discovery service rapidly and affordably. Their BinderGenᵀᴹ lead discovery platform generates diverse in vivo-derived monoclonal antibody binders in 6 weeks designed to empower downstream drug development applications including target validation, proof-of-concept, lead optimization, and multimodality engineering.